Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NADH:ubiquinone oxidoreductase subunit B4 pseudogene 8 (NDUFB4P8) is a processed pseudogene in the human genome that shares sequence similarity with the NDUFB4 gene, which encodes a component of mitochondrial Complex I in the oxidative phosphorylation pathway[3][9][1]. However, as a pseudogene, NDUFB4P8 lacks protein-coding potential and does not produce a functional protein[3]. No biological function, disease association, or therapeutic targeting has been demonstrated for this gene, and it is not considered a receptor, enzyme, transporter, or drug target. It is annotated in major databases but does not have known physiological or pathological roles[3][1][8]. Its primary significance is as a non-functional genomic region, sometimes used in genetic or genomic studies for comparative or evolutionary purposes[8]. In summary, NDUFB4P8 is a pseudogene, not an active receptor or therapeutic target, and its listing is likely incorrect for drug discovery or clinical biomarker purposes[1][3][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADH:ubiquinone oxidoreductase subunit B4 pseudogene 8 (NDUFB4P8).